Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Endocrine dysfunction and growth in children with medulloblastoma

소아 수모세포종 환자에서 치료 후의 내분비적 장애와 성장변화

  • Yoon, In Suk (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Seo, Ji Young (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Shin, Choong Ho (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Kim, Il Han (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Shin, Hee Young (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Yang, Sei Won (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Ahn, Hyo Seop (Department of Pediatrics, Seoul National University College of Medicine)
  • 윤인석 (서울대학교 의과대학 소아과학교실) ;
  • 서지영 (서울대학교 의과대학 소아과학교실) ;
  • 신충호 (서울대학교 의과대학 소아과학교실) ;
  • 김일한 (서울대학교 의과대학 방사선종양학교실) ;
  • 신희영 (서울대학교 의과대학 소아과학교실) ;
  • 양세원 (서울대학교 의과대학 소아과학교실) ;
  • 안효섭 (서울대학교 의과대학 소아과학교실)
  • Received : 2005.09.15
  • Accepted : 2005.10.25
  • Published : 2006.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : In medulloblastoma, craniospinal radiation therapy combined with chemotherapy improves the prognosis of tumors but results in significant endocrine morbidities. We studied the endocrine morbidity, especially growth pattern changes. Methods : The medical records of 37 patients with medulloblastoma were reviewed retrospectively for evaluation of endocrine function and growth. We performed the growth hormone stimulation test in 16 patients whose growth velocity was lower than 4 cm/yr. Results : The height loss was progressive in most patients. The height standard deviation score (SDS) decreased from $-0.1{\pm}1.3$ initially to $-0.6{\pm}1.0$ after 1 year(P<0.01). Growth hormone deficiency(GHD) developed in 14 patients. During the 2 years of growth hormone(GH) treatment, the improvements of height gain or progressions of height loss were not observed. Twelve patients(32.4 percent) revealed primary hypothyroidism. One of six patients diagnosed with compensated hypothyroidism progressed to primary hypothyroidism. Primary and hypergonadotropic hypogonadism were observed in two and one patients respectively. There was no proven case of central adrenal insufficiency. Conclusion : Growth impairment developed frequently, irrespective of the presence of GHD in childhood survivors of medulloblastoma. GH treatment may prevent further loss of height. The impairment of the hypothalamic-pituitary-gonadal and hypothalamic-pituitary-thyroidal axis is less common, while central adrenal insufficiency was not observed.

목 적 : 소아 수모세포종은 수술과 중추신경계 방사선조사 그리고 항암화학요법의 병합치료로 장기 생존율의 향상을 가져왔으나 성장호르몬결핍을 포함한 여러 내분비적 장애가 잘 발생하기에, 본 저자들은 수모세포종 치료 후 내분비적 장애와 성장변화를 관찰하고 해당 호르몬 치료의 성과를 분석하였다. 방 법 : 1986-2004년까지 서울대학교병원에서 수모세포종 치료를 마친 후 소아내분비 외래를 방문한 37명(남아 24명, 여아 13명)을 대상으로 내분비 장애와 성장변화에 대하여 분석하였다. 결 과 : 성장속도가 4 cm/yr 미만인 환자 중 16명에서 성장호르몬자극검사가 시행되었고 14명(전체환자 중 37.8%)이 성장호르몬결핍증으로 진단받았으며(완전 5명, 부분 9명), 2명의 환자는 신경분비장애로 의심되었다. 성장호르몬결핍증 환자군과 성장호르몬결핍이 없는 군 모두에서 방사선치료 전후의 키 표준편차 점수는 모두 유의한 감소를 보였으며(P<0.001), 성장호르몬결핍이 있는 12명과 신경분비장애가 있는 1명의 환자에게서 성장호르몬 치료를 시작하였다. 치료 전 골연령은 $9.3{\pm}4.7$세로 역연령에 비해 2.1세 저하되어 있었다. 치료 전 성장속도는 $3.4{\pm}1.2cm/yr$에서 1년째 $5.4{\pm}2.9cm/yr$로 유의하게 증가하였으나 키표준편차점수는 치료 전과 치료 후 유의한 변화가 없었다. 전체 37명 중 12명(32.4%)이 일차성 갑상선기능저하증으로 갑상선호르몬 치료를 받았다. 또한 다른 6명(16.2%)에서는 보상성 갑상선기능저하증이 의심되었다. 1명의 환자에서 방사선 치료종료 7년 후에 갑상선암이 발생하여 갑상선 전절제술을 시행 받은 후 갑상선호르몬을 복용 중이다. 성선자극호르몬결핍 1명(2%), 성선부전증이 2명(4%) 진단되었다. 결 론 : 수모세포종 치료 후 대부분 성장장애가 관찰되며 주로 성장호르몬결핍증과 척수방사선조사 등에 기인한다. 성장호르몬결핍증과 갑상선기능저하증 및 다른 내분비적 장애가 발생할 수 있으므로 지속적인 정기 추적 관찰 및 적절한 치료가 필요하다.

Keywords

References

  1. McNeil DE, Cote TR, Clegg L, Rorke LB. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor : a SEER update. surveillance epidemiology and end results. Med Pediatr Oncol 2002;39:190-4 https://doi.org/10.1002/mpo.10121
  2. Rood BR, Macdonald TJ, Packer RJ. Current treatment of medulloblastoma : recent advances and future challenges. Semin Oncol 2004;31:666-75 https://doi.org/10.1053/j.seminoncol.2004.07.009
  3. Brandes AA, Paris MK. Review of the prognostic factors in medulloblastoma of children and adults. Crit Rev Oncol Hematol 2004;50:121-8 https://doi.org/10.1016/j.critrevonc.2003.08.005
  4. Pasqualini T, Diez B, Domene H, Escobar ME, Gruneiro L, Heinrich J, et al. Long‐term endocrine sequelae after surgery, radiotherapy, and chemotherapy in children with medulloblastoma. Cancer 1987;59:801-6 https://doi.org/10.1002/1097-0142(19870215)59:4<801::AID-CNCR2820590424>3.0.CO;2-Z
  5. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long term endocrine sequelae after treatment of medulloblastoma. J Pediatr 1986;108:219-23 https://doi.org/10.1016/S0022-3476(86)80986-6
  6. Song CK, Lee SY, Jung MH, Song J, Lee K, Lee K, et al. Endocrine dysfunction following treatment of medulloblastoma. J Korean Soc Pediatr Endocrinol 1999;4:201-21
  7. Xu W, Janss A, Moshang T. Adult height and adult sitting height in childhood medulloblastoma survivors. J Clin Endocrinol Metab 2003;88:4677-81 https://doi.org/10.1210/jc.2003-030619
  8. Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R. GH deficiency caused by cranial irradiation during childhood : factors and markers in young adults. J Clin Endocrinol Metab 2001;86:5245-51 https://doi.org/10.1210/jc.86.11.5245
  9. Tan BC, Kunaratnam N. Hypopituitary dwarfism following radiotherapy for nasopharyngeal carcinoma. Clin Radiol 1966;17:302-4 https://doi.org/10.1016/S0009-9260(66)80043-0
  10. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol(Oxf) 1989;31:363-73 https://doi.org/10.1111/j.1365-2265.1989.tb01260.x
  11. Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr 1986;108:332
  12. Huang TS, Chen ST, Lui LT, Chang YL, Hsu MM. Early effects of cranial irradiation on hypothalamic pituitary function. J Formos Med Assoc 1990;89:541-7
  13. Brauner R, Rappaport R, Prevot C, Czernichow P, Zucker JM, Bataini P, et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab 1989;68:346-51 https://doi.org/10.1210/jcem-68-2-346
  14. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation‐induced growth hormone deficiency. J Pediatr 1991;118:226-8 https://doi.org/10.1016/S0022-3476(05)80487-1
  15. Chen MS, Lin FJ, Huang MJ, Wang PW, Tang S, Leung WM, et al. Prospective hormone study of hypothalamicpituitary function in patients with nasopharyngeal carcinoma after high dose irradiation. Jpn J Clin Oncol 1989;19: 265-70
  16. Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med 1991;78:265-74
  17. Bercu BB, Diamond FB Jr. Growth hormone neurosecretory dysfunction. Clin Endocrinol Metab 1986;15:537-90 https://doi.org/10.1016/S0300-595X(86)80010-X
  18. Spoudeas HA, Hindmarsh PC, Matthews DR, Brook CG. Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours : a prospective study. J Endocrinol 1996;150:329-42 https://doi.org/10.1677/joe.0.1500329
  19. Darzy KH, Shalet SM. Radiation-induced growth hormone deficiency. Horm Res 2003;59 Suppl 1:1-11
  20. Shalet SM, Gibson B, Swindell R, Pearson D. Effect of spinal irradiation on growth. Arch Dis Child 1987;62:461-4 https://doi.org/10.1136/adc.62.5.461
  21. Jakacki RI, Feldman H, Jamison C, Boaz JC, Luerssen TG, Timmerman R. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. Int J Radiat Oncol Biol Phys 2004; 60:531-6 https://doi.org/10.1016/j.ijrobp.2004.03.027
  22. Clayton PE, Shalet SM, Price DA. Growth response to growth hormone therapy following craniospinal irradiation. Eur J Pediatr 1988;147:597-601 https://doi.org/10.1007/BF00442471
  23. Sulmont V, Brauner R, Fontoura M, Rappaport R. Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Acta Paediatr Scand 1990;79:542-9 https://doi.org/10.1111/j.1651-2227.1990.tb11509.x
  24. Livesey EA, Hindmarsh PC, Brook CG, Whitton AC, Bloom HJ, Tobias JS, et al. Endocrine disorders following treatment of childhood brain tumours. Br J Cancer 1990;61:622-5 https://doi.org/10.1038/bjc.1990.138
  25. Ricardi U, Corrias A, Einaudi S, Genitori L, Sandri A, di Montezemolo LC, et al. Thyroid dysfunction as a late effect in childhood medulloblastoma. Int J Radiat Oncol Biol Phys 2001;50:1287-94 https://doi.org/10.1016/S0360-3016(01)01519-X
  26. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr 1991;119:733-7 https://doi.org/10.1016/S0022-3476(05)80288-4
  27. Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000;18:348-57 https://doi.org/10.1200/JCO.2000.18.2.348
  28. Gleeson HK, Shalet SM. Endocrine complications of neoplastic diseases in children and adolescents. Curr Opin Pediatr 2001;13:346-51 https://doi.org/10.1097/00008480-200108000-00011
  29. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999;84:4472-9 https://doi.org/10.1210/jc.84.12.4472
  30. Livesey EA, Brook CG. Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child 1988;63:495-500 https://doi.org/10.1136/adc.63.5.495
  31. Stillman RJ, Schinfeld JS, Schiff I, Gelber RD, Greenberger J, Larson M, et al. Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 1981;139:62-6 https://doi.org/10.1016/0002-9378(81)90413-0
  32. Ahmed SR, Shalet SM, Campbell RH, Deakin DP. Primary gonadal damage following treatment of brain tumors in childhood. J Pediatr 1983;103:562-5. https://doi.org/10.1016/S0022-3476(83)80584-8
  33. Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994;78:1282-6 https://doi.org/10.1210/jc.78.6.1282